The common practice of excluding patients with a prior cancer diagnosis from lung cancer clinical trials may not be justified, according to a study by researchers from UT Southwestern Medical Center.
Feb 09, 2015
1 / 5 (1) | 0
A team at the Institute of Neurosciences, joint centre of the Miguel Hernández University (UMH) in Elche and the Spanish National Research Council (CSIC), has published a paper titled "Heteromers of amyloid ...
Feb 04, 2015
not rated yet | 0